BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 26503923)

  • 1. Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.
    Klingelhoefer L; Reichmann H
    Nat Rev Neurol; 2015 Nov; 11(11):625-36. PubMed ID: 26503923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson disease: the enteric nervous system spills its guts.
    Derkinderen P; Rouaud T; Lebouvier T; Bruley des Varannes S; Neunlist M; De Giorgio R
    Neurology; 2011 Nov; 77(19):1761-7. PubMed ID: 22067963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
    Holmqvist S; Chutna O; Bousset L; Aldrin-Kirk P; Li W; Björklund T; Wang ZY; Roybon L; Melki R; Li JY
    Acta Neuropathol; 2014 Dec; 128(6):805-20. PubMed ID: 25296989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.
    Cersosimo MG; Benarroch EE
    Neurobiol Dis; 2012 Jun; 46(3):559-64. PubMed ID: 22048068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
    Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
    Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Parkinson's disease start in the gut?
    Lionnet A; Leclair-Visonneau L; Neunlist M; Murayama S; Takao M; Adler CH; Derkinderen P; Beach TG
    Acta Neuropathol; 2018 Jan; 135(1):1-12. PubMed ID: 29039141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms].
    Takeda A; Baba T; Kikuchi A; Sugeno N; Hasegawa T; Itoyama Y; Ishioka T; Hirayama K; Mori E
    Rinsho Shinkeigaku; 2009 Nov; 49(11):888-9. PubMed ID: 20030239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
    Kujawska M; Jodynis-Liebert J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.
    Pan-Montojo F; Anichtchik O; Dening Y; Knels L; Pursche S; Jung R; Jackson S; Gille G; Spillantini MG; Reichmann H; Funk RH
    PLoS One; 2010 Jan; 5(1):e8762. PubMed ID: 20098733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
    Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
    Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural control of the gastrointestinal tract: implications for Parkinson disease.
    Cersosimo MG; Benarroch EE
    Mov Disord; 2008 Jun; 23(8):1065-75. PubMed ID: 18442139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance.
    Travagli RA; Browning KN; Camilleri M
    Nat Rev Gastroenterol Hepatol; 2020 Nov; 17(11):673-685. PubMed ID: 32737460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where and how alpha-synuclein pathology spreads in Parkinson's disease.
    Wakabayashi K
    Neuropathology; 2020 Oct; 40(5):415-425. PubMed ID: 32750743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
    Liu Y; Sun JD; Song LK; Li J; Chu SF; Yuan YH; Chen NH
    Behav Brain Res; 2015 Nov; 294():149-61. PubMed ID: 26239001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease and Its Counterpart in Peroral Prion Infections.
    Beekes M
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constipation: an emerging risk factor for Parkinson's disease?
    Stirpe P; Hoffman M; Badiali D; Colosimo C
    Eur J Neurol; 2016 Nov; 23(11):1606-1613. PubMed ID: 27444575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system.
    Pan-Montojo FJ; Funk RH
    J Vis Exp; 2010 Oct; (44):. PubMed ID: 21085094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.